| |
| |
|
| Insider
Information: |
Cauwenbergh Geert |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
42,152 |
|
|
Indirect Shares
|
450 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
42,602 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Point Therapeutics Inc |
POTP |
Director |
2009-01-08 |
37,917 |
2008-07-15 |
0 |
Premium* |
|
|
Phio Pharmaceuticals Corp |
PHIO |
Director |
2023-02-17 |
4,235 |
2019-11-18 |
450 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PHIO |
Phio Pharmaceuticals Corp |
Director |
– • – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
4,235 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
Director |
– • – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
32,822 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
Director |
– • – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
22,822 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
Director |
– • – |
2019-11-18 |
4 |
A |
$0.10 |
$22,500 |
D/D |
225,000 |
704,841 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
Director |
– • – |
2019-08-01 |
4 |
D |
$0.40 |
$706 |
D/D |
(1,751) |
479,841 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
Chief Executive Officer |
• • – |
2019-02-28 |
4 |
A |
$0.38 |
$57,887 |
D/D |
152,415 |
481,592 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
Chief Executive Officer |
• • – |
2019-02-15 |
4 |
A |
$0.36 |
$8,096 |
D/D |
22,279 |
329,177 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
Chief Executive Officer |
• • – |
2019-02-01 |
4 |
A |
$0.38 |
$8,096 |
D/D |
21,470 |
306,898 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
Chief Executive Officer |
• • – |
2019-01-18 |
4 |
A |
$0.34 |
$8,096 |
D/D |
23,729 |
285,428 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
Chief Executive Officer |
• • – |
2019-01-04 |
4 |
A |
$0.35 |
$8,096 |
D/D |
23,139 |
261,699 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
Chief Executive Officer |
• • – |
2018-12-21 |
4 |
A |
$0.30 |
$8,096 |
D/D |
27,445 |
238,560 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
Chief Executive Officer |
• • – |
2018-12-07 |
4 |
A |
$0.37 |
$8,096 |
D/D |
21,882 |
211,115 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
Chief Executive Officer |
• • – |
2018-11-23 |
4 |
A |
$0.31 |
$8,096 |
D/D |
25,941 |
189,233 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
President & CEO |
• • – |
2018-11-09 |
4 |
A |
$0.43 |
$8,096 |
D/D |
18,698 |
163,292 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
President & CEO |
• • – |
2018-10-26 |
4 |
A |
$0.44 |
$8,097 |
D/D |
18,519 |
144,594 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
President & CEO |
• • – |
2018-10-12 |
4 |
A |
$0.47 |
$8,096 |
D/D |
17,230 |
126,075 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
President & CEO |
• • – |
2018-09-28 |
4 |
A |
$1.17 |
$86,097 |
D/D |
73,587 |
108,845 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
President & CEO |
• • – |
2018-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
35,258 |
0 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
President & CEO |
• • – |
2017-10-02 |
4 |
B |
$0.44 |
$4,475 |
D/D |
10,000 |
142,583 |
2.73 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
President & CEO |
• • – |
2017-08-24 |
4 |
B |
$0.55 |
$5,483 |
D/D |
10,000 |
132,583 |
2.81 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
President & CEO |
• • – |
2017-06-22 |
4 |
B |
$0.62 |
$6,250 |
D/D |
10,000 |
122,583 |
2.81 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
President & CEO |
• • – |
2017-04-26 |
4 |
B |
$0.65 |
$6,480 |
D/D |
10,000 |
112,583 |
2.81 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
President & CEO |
• • – |
2017-03-17 |
4 |
B |
$0.77 |
$7,692 |
D/D |
10,000 |
102,583 |
2.81 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
President & CEO |
• • – |
2017-02-17 |
4 |
B |
$0.69 |
$6,931 |
D/D |
10,000 |
92,583 |
2.81 |
- |
|
| PHIO |
Phio Pharmaceuticals Corp |
President & CEO |
• • – |
2017-02-08 |
4 |
B |
$0.69 |
$6,850 |
D/D |
10,000 |
82,583 |
2.81 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
